Kawano Kenji, Yanagisawa Shigetaka
Department of Oncological Science, Division of Oral and Maxillo-Facial Surgery, Faculty of Medicine, Oita University, 1 Idaigaoka, Hasama-machi, Oita 879-5593, Japan.
Head Neck. 2006 Jun;28(6):525-33. doi: 10.1002/hed.20349.
Laminin-5 (Ln-5) cleaved by membrane type 1-matrix metalloproteinase (MT1-MMP) enhances the migration of tumor cells. The purpose of this study was to determine whether or not enhanced expression of both Ln-5 and MT1-MMP was associated with lymph node metastasis in patients with T1 and T2 squamous cell carcinoma (SCC) of the tongue and floor of the mouth.
By use of biopsy specimens of primary tumors from 57 patients, intratumoral expression of Ln-5 and MT1-MMP was evaluated immunohistochemically and its association with node metastasis analyzed.
The tumors were categorized into three groups: Ln-5 focal type/MT1-MMP (-) (group I, n = 14), Ln-5 focal type/ MT1-MMP (+) and Ln-5 diffuse type/MT1-MMP (-) (group II, n = 16), and Ln-5 diffuse type/MT1-MMP (+) (group III, n = 27). The incidence of node metastasis (initial and latent metastases) was two of 14 (14.3%), five of 16 (31.3%), and 15 of 27 (55.6%) in groups I, II, and III, respectively. Multivariate analysis identified tumor thickness (odds ratio, 4.751; p = .0152) and Ln-5/ MT1-MMP expression (odds ratio, 3.795, p = .0304) as independent factors of node metastasis. Moreover, in 35 patients with N0 disease, Ln-5/MT1-MMP expression was the only parameter associated with latent node metastasis (odds ratio, 12.800, p = .0247).
These results suggest that immunohistochemical evaluation of Ln-5 and MT1-MMP expression is useful for identifying patients with T1 and T2 SCC of the tongue and floor of the mouth who should be treated with elective neck dissection.
被膜型1-基质金属蛋白酶(MT1-MMP)切割的层粘连蛋白-5(Ln-5)可增强肿瘤细胞的迁移能力。本研究旨在确定Ln-5和MT1-MMP的表达增强是否与舌及口底T1和T2期鳞状细胞癌(SCC)患者的淋巴结转移相关。
利用57例患者原发肿瘤的活检标本,采用免疫组织化学方法评估肿瘤内Ln-5和MT1-MMP的表达,并分析其与淋巴结转移的关系。
肿瘤分为三组:Ln-5局灶型/MT1-MMP(-)(I组,n = 14)、Ln-5局灶型/MT1-MMP(+)和Ln-5弥漫型/MT1-MMP(-)(II组,n = 16)、Ln-5弥漫型/MT1-MMP(+)(III组,n = 27)。I组、II组和III组的淋巴结转移(初始和潜在转移)发生率分别为14例中的2例(14.3%)、16例中的5例(31.3%)和27例中的15例(55.6%)。多因素分析确定肿瘤厚度(比值比,4.751;p = 0.0152)和Ln-5/MT1-MMP表达(比值比,3.795,p = 0.0304)为淋巴结转移的独立因素。此外,在35例N0期疾病患者中,Ln-5/MT1-MMP表达是与潜在淋巴结转移相关的唯一参数(比值比,12.800,p = 0.0247)。
这些结果表明,对Ln-5和MT1-MMP表达进行免疫组织化学评估有助于识别舌及口底T1和T2期SCC患者,这些患者应接受选择性颈清扫术治疗。